Animal studies hint that alcohol and cannabinoids may interact to alter development; experts urge avoiding both during pregnancy amid uncertain human risk.
Endocannabinoids help mice adapt to stress at hippocampus–amygdala synapses, hinting at targeted therapies—yet not proven in humans.
CBD slowed melanoma growth in mice, hinting at potential cancer research avenues—but this early study doesn't prove safety or effectiveness in humans.
One in three cancer patients used cannabis after diagnosis, per a Memorial Sloan Kettering survey—why they used it and gaps in clinician discussion.
Design a cannabis testing lab around workflow, safety, and compliance—learn planning steps, regulatory coordination, and robust utilities to cut risk and cost.
Three-month QUEST study links prescribed medicinal cannabis to better quality of life and symptom relief for chronic conditions in Australia.
CBD for arthritis shows promise for pain relief, but evidence isn’t enough to replace steroids—explore the benefits, risks, and the limits of current research.
CBD may help resolve inflammation by steering immune cells toward pro-resolving signals via a lipid mediator switch and 15-LOX-1 activation, opening avenues.
Explore USDA's hemp germplasm initiative: standardized phenotyping and a searchable database that fuels breeding and research for fiber, seed, and oil traits.
How the 2018 Farm Bill opened hemp research yet kept a fuzzy regulatory maze—exploring what’s legal, who regulates it, and what’s ahead for industry.